Skip to main content
Advertisement
Advertisement

ASTH

ASTH logo

Astrana Health Inc. Common Stock

36.37
USD
Sponsored
+1.93
+5.60%
Sep 25, 15:59 UTC -4
Closed
exchange

After-Market

36.34

-0.03
-0.10%

ASTH Earnings Reports

Positive Surprise Ratio

ASTH beat 20 of 33 last estimates.

61%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.04B
/
$0.47
Implied change from Q2 26 (Revenue/ EPS)
+6.99%
/
+17.50%
Implied change from Q3 25 (Revenue/ EPS)
+8.83%
/
+4600.00%

Astrana Health Inc. Common Stock earnings per share and revenue

On Aug 06, 2026, ASTH reported earnings of 0.40 USD per share (EPS) for Q2 26, beating the estimate of 0.34 USD, resulting in a 16.72% surprise. Revenue reached 972.52 million, compared to an expected 1.01 billion, with a -3.27% difference. The market reacted with a +4.78% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of 0.47 USD, with revenue projected to reach 1.04 billion USD, implying an increase of 17.50% EPS, and increase of 6.99% in Revenue from the last quarter.
FAQ
For Q2 2026, Astrana Health Inc. Common Stock reported EPS of $0.40, beating estimates by 16.72%, and revenue of $972.52M, -3.27% below expectations.
The stock price moved up 4.78%, changed from $34.13 before the earnings release to $35.76 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on 9 analysts, Astrana Health Inc. Common Stock is expected to report EPS of $0.47 and revenue of $1.04B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement